Loading...
Loading...
By Sofía Garduño - Thu, 12/05/2024 - 12:06
COFEPRIS approves LEQEMBI for early Alzheimer’s disease, which reduces disease progression and cognitive decline.
https://mexicobusiness.news/tag/biogen
More Health
By MBN Staff - Wed, 07/31/2024 - 17:22
Leqembi's data shows a 31% reduction in cognitive decline, with no new safety issues, contrasting with Lilly’s Kisunla in cost and approach.
By Miriam Bello - Fri, 11/19/2021 - 17:04
2021 is a breakthrough year for Alzheimer with the development of better diagnostic tools and a potential treatment.
By Miriam Bello - Tue, 09/21/2021 - 17:05
Two novel solutions aim to change the detection and treatment of this neurodegenerative disease.
By - Thu, 09/06/2018 - 15:20
Mexico Health Summit 2018: How to Increase the Productivity of a Country Through Health? panel highlights
